Reaction Biology Europe has provided their services for several projects with us, including establishing an orthotopic tumor model and PK/PD studies. I was very impressed, not only by their level of expertise and professionalism but also by their enthusiasm and drive to deliver. The insightful advice they provide has been instrumental to our successes and their collegial and “can do” attitude make them a pleasure to team up with!
I have worked with Reaction Biology Europe and Reaction Biology Corp. for more than 5 years on several interesting projects. These have ranged from routine enzyme screening to more complex kinome-scan and in-cell target engagement work. The results of these endeavors have led to a series of top-tier publications. This coupled with exceptional customer service means I have no hesitation to recommend Reaction Biology Corp. and Reaction Biology Europe as research partners.
Reaction Biology Europe has provided their service for numerous projects with us, especially on multiple kinase assays (under the name ProQinase) which have guided our way through drug development. I was very impressed not only by their level of expertise and professionalism but also by their enthusiasm and drive to deliver without delay. The insightful advice they provide has been instrumental to our successes, and the reproducibility, quality, and reporting of the results have been outstanding throughout the many years we have been working together.
We have worked with Reaction Biology Europe for 3 years on in vivo drug development assays. They have provided their services from routine PK through efficacy and custom BLI studies in tumor models, consistently generating high-quality results that guided our development process. Their expertise, responsiveness, and professionalism make Reaction Biology stand out from among the usual CROs, and we are happy to recommend them as research partners.
We have founded two companies for drug discovery in extremely challenging sectors - epitranscriptomics and phosphatase biology. For both projects we have partnered with Reaction Biology. Tackling drug discovery projects that are based on novel and rapidly evolving science requires a CRO with profound know-how and a specific mindset - a focus on customers, the ability to think out of the box, and the capability to provide highly customized screening and assay solutions. We found all that in our relationship with Reaction Biology.
Discovery on Target
The industry’s preeminent event on novel drug targets and technologies
ELRIG Drug Discovery
After the Storm: Re-Connect, Re-Invent, Re-Imagine. Europe’s largest meeting for life sciences…
Immuno Series US
Discuss the latest strategies to harness the immune system for the development of innovative…
Discovery Series UK
An in-person event to meet our scientists heading our biophysical and KRAS-related service units…
Immuno Series UK
Join us at our first in-person meeting this year to explore our immuno-oncology platform.
COVID-19 /SARS-CoV2 update
Dear customers,
all Reaction Biology research facilities are and remain fully operational under safe work environment guidelines. Our business will not close due to lockdown restrictions in Europe. Our sales staff and business development team are happy to discuss any project with you. Please reach out!
Cooperation with 4HF Biotec to provide new Bioinformatic Cell Service
In cooperation with the bioinformatics firm 4HF Biotec, we announce the offering of a combination of the ProLiFiler cell panel screening service with 4HF‘s bioinformatic evaluation of the drug‘s profile.
ProQinase is now Reaction Biology Europe
ProQinase rebranding into Reaction Biology Europe GmbH was performed completing the process of acquiring ProQinase. As this only represents a change of name, all contracts with former ProQinase remain valid and binding. All ProQinase products and services are continued and available within the Reaction Biology portfolio.